Paul Foerster
Overview
Explore the profile of Paul Foerster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foerster P, Klaas J, Furweger C, Ehret F, Muacevic A, Santacroce A
Cureus
. 2024 Jun;
16(5):e59859.
PMID: 38854187
Stereotactic radiosurgery (SRS) is a well-established treatment modality for the management of uveal melanoma, achieving high tumor control and eye retention rates. There are several SRS treatment platforms available, including...
2.
Ehret F, Furweger C, Liegl R, Schmelter V, Priglinger S, Subedi G, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(4):1052-1057.
PMID: 38838993
Purpose: Uveal melanoma (UM), although a rare malignancy, stands as the most prevalent intraocular malignancy in adults. Controversies persist regarding the dose dependency of local control (LC) through radiation therapy....
3.
Herr P, Brantl V, Priglinger S, Foerster P, Thurau S
Ocul Immunol Inflamm
. 2024 Apr;
32(9):2280-2284.
PMID: 38579172
We report two patients who displayed evidence of localized ocular inflammation after CAR T-cell infusion. To manage the resulting severe visual impairment, systemic corticosteroids were administered to both patients. This...
4.
Ruf T, Leonhardt A, Anz D, Kunz W, Rohrle N, Foerster P, et al.
Immunotherapy
. 2023 Sep;
15(16):1363-1368.
PMID: 37661909
Tebentafusp, a bispecific T-cell receptor fusion protein directed against gp100 and CD3, can improve survival in patients with metastatic uveal melanoma and was recently approved for the treatment of -positive...
5.
Schmelter V, Schneider F, Guenther S, Fuerweger C, Muacevic A, Priglinger S, et al.
Ocul Oncol Pathol
. 2023 Mar;
8(4-6):221-229.
PMID: 36925728
Introduction: Tumor recurrence in choroidal melanoma has been associated with decreased overall survival due to metastatic spreading. To detect risk factors of local recurrence and side effects, we analyzed tumor...
6.
Liegl R, Schmelter V, Fuerweger C, Ehret F, Priglinger S, Muacevic A, et al.
Am J Ophthalmol
. 2023 Jan;
250:177-185.
PMID: 36642391
Purpose: To present the results of robotic-assisted radiosurgery in choroidal and ciliary body melanomas treated at the Department of Ophthalmology of Ludwig-Maximilians-University and the European CyberKnife Center in Munich, Germany....
7.
Schmelter V, Schneider F, Priglinger S, Liegl R, Kreutzer T, Foerster P
Int Ophthalmol
. 2022 Sep;
43(4):1111-1119.
PMID: 36066783
Purpose: Endophthalmitis is a severe inflammation following surgery or endogenous spread of pathogens. Besides clinical signs and symptoms, standardized ultrasound might help to confirm the diagnosis. Thus, we analyzed 172...
8.
Schmelter V, Hofmann T, Schneider F, Weber C, Fuerweger C, Muacevic A, et al.
Melanoma Res
. 2022 Apr;
32(3):192-199.
PMID: 35404316
Plaque brachytherapy is the most common procedure for the treatment of small choroidal melanoma, especially in posteriorly located tumors. However, there is only little information on outcome after treatment with...
9.
Schmelter V, Heidorn S, Muacevic A, Priglinger S, Foerster P, Liegl R
Sci Rep
. 2021 Mar;
11(1):5685.
PMID: 33707492
Iris melanoma is a rare form of uveal melanoma with potential metastic spread. Treatment options include surgical resection, enucleation or irradiation. We analysed visual outcome, complication appearance and management in...
10.
Schmelter V, Heidorn S, Fuerweger C, Muacevic A, Priglinger S, Foerster P, et al.
Eye (Lond)
. 2021 Feb;
35(12):3376-3383.
PMID: 33574560
Purpose: Choroidal metastases occur in many patients with systemic cancer and limit quality of life due to visual deterioration or pain. The limited prognosis of these patients demand treatment approaches...